We are live on ! Find out more
MBII

Marrone Bio Innovations, Inc.

Delisted

MBII was delisted on the 12th of July, 2022.

74 hedge funds and large institutions have $32.6M invested in Marrone Bio Innovations, Inc. in 2021 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 18 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 18

1% more funds holding

Funds holding: 7374 (+1)

8% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 12

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

31% less capital invested

Capital invested by funds: $47.1M → $32.6M (-$14.5M)

Holders
74
Holders Change
+1
Holders Change %
+1.37%
% of All Funds
1.14%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
13
Increased
22
Reduced
18
Closed
12
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of America
26
Bank of America
North Carolina
$61K +$35.5K +43,906 +107%
VF
27
Virtu Financial
New York
$57K +$44.8K +55,371 +237%
CHAM
28
Clear Harbor Asset Management
Connecticut
$55K +$17.8K +22,027 +41%
RhumbLine Advisers
29
RhumbLine Advisers
Massachusetts
$52K -$398 -492 -0.7%
Two Sigma Investments
30
Two Sigma Investments
New York
$51K +$5.12K +6,330 +10%
Deutsche Bank
31
Deutsche Bank
Germany
$45K +$2.59K +3,206 +5%
DC
32
Davenport & Co
Virginia
$44K -$48.5K -60,000 -49%
Wells Fargo
33
Wells Fargo
California
$44K +$43K +53,132 +677%
Renaissance Technologies
34
Renaissance Technologies
New York
$43K -$191K -235,900 -80%
AIG
35
American International Group
New York
$39K -$831 -1,027 -2%
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$39K
PTC
37
Philadelphia Trust Company
Pennsylvania
$39K +$43.3K +53,500 New
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
$34K
BCV
39
Banque Cantonale Vaudoise
Switzerland
$33K
Nomura Holdings
40
Nomura Holdings
Japan
$33K +$37.9K +46,860 New
Invesco
41
Invesco
Georgia
$25K -$862 -1,066 -3%
State Board of Administration of Florida Retirement System
42
State Board of Administration of Florida Retirement System
Florida
$23K
Two Sigma Advisers
43
Two Sigma Advisers
New York
$21K +$5.99K +7,400 +33%
MWM
44
Meridian Wealth Management
Kentucky
$20K +$22.5K +27,819 New
Jane Street
45
Jane Street
New York
$20K +$22.5K +27,851 New
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
$19K +$10.3K +12,785 +102%
Citigroup
47
Citigroup
New York
$18K +$10.8K +13,324 +108%
Victory Capital Management
48
Victory Capital Management
Texas
$17K -$483 -597 -3%
HSBC Holdings
49
HSBC Holdings
United Kingdom
$17K
SEP
50
Southland Equity Partners
Missouri
$15.8K

MBII Hedge Fund Activity: Q4 2021 in Review

74 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q4 2021, worth a combined $32.6M — down 31% from $47.1M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new MBII positions and 12 closed out — a net gain of 1 holder — while 22 added to existing stakes and 18 trimmed.

The largest buyer was Shay Capital, adding an estimated $3.13M. The largest seller was Macquarie Group, exiting entirely with an estimated $15.2M sold.

  • 74 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q4 2021, up from 73 in Q3 2021.
  • Funds reported $32.6M of Marrone Bio Innovations, Inc. stock for Q4 2021, down 31% quarter-over-quarter.
  • 13 funds opened new Marrone Bio Innovations, Inc. positions in Q4 2021 and 12 closed out, a net change of +1 holder.
  • The largest Marrone Bio Innovations, Inc. buyer in Q4 2021 was Shay Capital, an estimated $3.13M added.
  • The largest Marrone Bio Innovations, Inc. seller in Q4 2021 was Macquarie Group, an estimated $15.2M sold.

Based on aggregated 13F filings for Q4 2021.